BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 16897432)

  • 21. Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer.
    Inoue Y; Yamashita N; Kitao H; Tanaka K; Saeki H; Oki E; Oda Y; Tokunaga E; Maehara Y
    Clin Breast Cancer; 2018 Aug; 18(4):e643-e650. PubMed ID: 29275106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of the ATM/ATR-mediated DNA damage response by the oncogenic phosphatase PPM1D.
    Lu X; Nguyen TA; Donehower LA
    Cell Cycle; 2005 Aug; 4(8):1060-4. PubMed ID: 15970689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Wip1 phosphatase PPM1D dephosphorylates SQ/TQ motifs in checkpoint substrates phosphorylated by PI3K-like kinases.
    Yamaguchi H; Durell SR; Chatterjee DK; Anderson CW; Appella E
    Biochemistry; 2007 Nov; 46(44):12594-603. PubMed ID: 17939684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p16Ink4a suppression of lung adenocarcinoma by Bmi-1 in the presence of p38 activation.
    Lee MO; Lee HJ; Kim MA; Kim EK; Lee JH; Heo JH; Lee SH; Cho SH; Fornace AJ; Jeong HC; Cha HJ
    J Thorac Oncol; 2011 Mar; 6(3):423-31. PubMed ID: 21164364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silencing of PPM1D inhibits cell proliferation and invasion through the p38 MAPK and p53 signaling pathway in papillary thyroid carcinoma.
    Lu ZW; Wen D; Wei WJ; Han LT; Xiang J; Wang YL; Wang Y; Liao T; Ji QH
    Oncol Rep; 2020 Mar; 43(3):783-794. PubMed ID: 31922231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Over-expression of wild-type p53-induced phosphatase 1 confers poor prognosis of patients with gliomas.
    Liang C; Guo E; Lu S; Wang S; Kang C; Chang L; Liu L; Zhang G; Wu Z; Zhao Z; Ma S; Wang L; Jiao BH
    Brain Res; 2012 Mar; 1444():65-75. PubMed ID: 22325093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wip1 phosphatase modulates ATM-dependent signaling pathways.
    Shreeram S; Demidov ON; Hee WK; Yamaguchi H; Onishi N; Kek C; Timofeev ON; Dudgeon C; Fornace AJ; Anderson CW; Minami Y; Appella E; Bulavin DV
    Mol Cell; 2006 Sep; 23(5):757-64. PubMed ID: 16949371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PPM1D phosphatase, a target of p53 and RBM38 RNA-binding protein, inhibits p53 mRNA translation via dephosphorylation of RBM38.
    Zhang M; Xu E; Zhang J; Chen X
    Oncogene; 2015 Nov; 34(48):5900-11. PubMed ID: 25823026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase.
    Fujimoto H; Onishi N; Kato N; Takekawa M; Xu XZ; Kosugi A; Kondo T; Imamura M; Oishi I; Yoda A; Minami Y
    Cell Death Differ; 2006 Jul; 13(7):1170-80. PubMed ID: 16311512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of Wip1 sensitizes cells to stress- and DNA damage-induced apoptosis.
    Xia Y; Ongusaha P; Lee SW; Liou YC
    J Biol Chem; 2009 Jun; 284(26):17428-37. PubMed ID: 19395378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The structure and expression of the murine wildtype p53-induced phosphatase 1 (Wip1) gene.
    Choi J; Appella E; Donehower LA
    Genomics; 2000 Mar; 64(3):298-306. PubMed ID: 10756097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WIP1 phosphatase as a potential therapeutic target in neuroblastoma.
    Richter M; Dayaram T; Gilmartin AG; Ganji G; Pemmasani SK; Van Der Key H; Shohet JM; Donehower LA; Kumar R
    PLoS One; 2015; 10(2):e0115635. PubMed ID: 25658463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual roles for the phosphatase PPM1D in regulating progesterone receptor function.
    Proia DA; Nannenga BW; Donehower LA; Weigel NL
    J Biol Chem; 2006 Mar; 281(11):7089-101. PubMed ID: 16352595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells.
    Chen L; Mayer JA; Krisko TI; Speers CW; Wang T; Hilsenbeck SG; Brown PH
    Cancer Res; 2009 Dec; 69(23):8853-61. PubMed ID: 19920204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wip1 over-expression correlated with TP53/p14(ARF) pathway disruption in human astrocytomas.
    Wang P; Rao J; Yang H; Zhao H; Yang L
    J Surg Oncol; 2011 Nov; 104(6):679-84. PubMed ID: 21695702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of Wild-Type p53-Induced Phosphatase 1 Confers Poor Prognosis of Patients with Nasopharyngeal Carcinoma.
    Sun GG; Zhang J; Ma XB; Wang YD; Cheng YJ; Hu WN
    Pathol Oncol Res; 2015 Apr; 21(2):283-91. PubMed ID: 25060857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D.
    Castellino RC; De Bortoli M; Lu X; Moon SH; Nguyen TA; Shepard MA; Rao PH; Donehower LA; Kim JY
    J Neurooncol; 2008 Feb; 86(3):245-56. PubMed ID: 17932621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The type 2C phosphatase Wip1: an oncogenic regulator of tumor suppressor and DNA damage response pathways.
    Lu X; Nguyen TA; Moon SH; Darlington Y; Sommer M; Donehower LA
    Cancer Metastasis Rev; 2008 Jun; 27(2):123-35. PubMed ID: 18265945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint.
    Kleiblova P; Shaltiel IA; Benada J; Ševčík J; Pecháčková S; Pohlreich P; Voest EE; Dundr P; Bartek J; Kleibl Z; Medema RH; Macurek L
    J Cell Biol; 2013 May; 201(4):511-21. PubMed ID: 23649806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LZAP inhibits p38 MAPK (p38) phosphorylation and activity by facilitating p38 association with the wild-type p53 induced phosphatase 1 (WIP1).
    An H; Lu X; Liu D; Yarbrough WG
    PLoS One; 2011 Jan; 6(1):e16427. PubMed ID: 21283629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.